Jamie Christensen - 16 Dec 2022 Form 4 Insider Report for Mirati Therapeutics, Inc.

Role
EVP, Chief Scientific Officer
Signature
/s/ Reena Desai, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
16 Dec 2022
Net transactions value
-$103,624
Form type
4
Filing time
20 Dec 2022, 15:02:00 UTC
Previous filing
05 Dec 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale $103,624 -2,410 -2.3% $43.00 102,072 16 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the performance stock units (PSUs) granted on June 25, 2021.